Personal information

Emails & domains

Verified email addresses

Verified email domains

Keywords

GI Malignancies, Hepatocellular carcinoma

Countries

France

Activities

Collapse all

Employment (1)

Institut de cancérologie de l'Ouest, Saint Herblain: Saint Herblain, Pays de la Loire, FR

Prof (Medical Oncology)
Employment
Source: Self-asserted source
Jean-Luc Raoul

Works (50 of 327)

Items per page:
Page 1 of 7

PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial

European Journal of Surgical Oncology
2024-09 | Journal article
DOI: 10.1016/j.ejso.2024.108468
Contributors: Frédéric Dumont; Vahan Kepenekian; Christophe Passot; Anne-Cécile Ezanno-Manasterski; Marc Pocard; Jean-Luc Raoul; Bénédicte Lelièvre; Sandrine Hiret; Hélène Senellart; Francois Pein et al.
Source: check_circle
Crossref

How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive Oncology

Current Oncology
2024-06 | Journal article | Author
DOI: 10.3390/curroncol31060259
Contributors: Elodie Martin; Karine Le Malicot; Catherine GUERIN-CHARBONNEL; François Bocquet; Olivier BOUCHE; Anthony Turpin; Thomas APARICIO; Jean-Louis Legoux; Laetitia Dahan; Julien Taieb et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)

Cancers
2023-09 | Journal article | Author
DOI: 10.3390/cancers15194777
Contributors: valerie Seegers; Guillaume ROUSSEAU; Ke ZHOU; Audrey Blanc-Lapierre; Frédéric Bigot; Hakim Mahammedi; Aurélien Lambert; Camille Moreau-Bachelard; Mario Campone; Thierry Conroy et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure

ESMO Open
2023-02 | Journal article
DOI: 10.1016/j.esmoop.2023.100880
Contributors: J.L. Raoul; C. Moreau-Bachelard; M. Gilabert; J. Edeline; J.S. Frénel
Source: check_circle
Crossref

Prolonged response on olaparib maintenance in metastatic pancreatic acinar cell carcinoma associated with a germline BRCA 2 mutation, revealed by severe panniculitis

Clinical Case Reports
2022-12 | Journal article
DOI: 10.1002/ccr3.6718
Contributors: Margaux Lelong; Jean‐Luc Raoul; Yann Touchefeu; Jean‐Marie Berthelot; Paul Arnolfo; Tamara Matysiak‐Budnik; Hélène Senellart
Source: check_circle
Crossref

COVID-19 Vaccination Campaign in Cancer Patients and Healthcare Workers-Results from a French Prospective Multicenter Cohort (PAPESCO-19)

Cancers
2022-11 | Journal article | Author
DOI: 10.3390/cancers14225547
Contributors: valerie Seegers; Guillaume ROUSSEAU; Ke Zhou; Audrey Blanc-Lapierre; Frédéric Bigot; Hakim Mahammedi; Aurélien Lambert; Camille Moreau-Bachelard; Mario Campone; Thierry Conroy et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations

Cancers
2022-11-28 | Journal article
DOI: 10.3390/cancers14235868
Contributors: Julien Edeline; Tim Meyer; Jean-Frédéric Blanc; Jean-Luc Raoul
Source: check_circle
Crossref

Effect of Concomitant Proton Pump Inhibitors with Pazopanib on Cancer Patients: A Retrospective Analysis

Cancers
2022-09 | Journal article | Author
DOI: 10.3390/cancers14194721
Contributors: Camille Moreau-Bachelard; Valentin Letailleur; Emmanuelle Bompas; Patrick Soulié; Julie Paul; Jean-Luc Raoul
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper

Cancers
2022-02 | Journal article | Author
DOI: 10.3390/cancers14051156
Contributors: Jean-Luc Raoul; Julien Edeline; Victor Simmet; Camille Moreau-Bachelard; Marine Gilabert; Jean-Sebastien FRENEL
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

COVID-19 Infections in Cancer Patients Were Frequently Asymptomatic: Description From a French Prospective Multicenter Cohort (PAPESCO-19)

Clinical Medicine Insights: Oncology
2022-01 | Journal article
DOI: 10.1177/11795549221090187
Contributors: Ke Zhou; Jean-Luc Raoul; Audrey Blanc-Lapierre; Valérie Seegers; Michèle Boisdron-Celle; Marianne Bourdon; Hakim Mahammedi; Aurélien Lambert; Camille Moreau-Bachelard; Mario Campone et al.
Source: check_circle
Crossref

Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients—First Results from the PAPESCO-19 Cohort Study

Cancers
2021-07 | Journal article | Author
DOI: 10.3390/cancers13143389
Contributors: Ke Zhou; Audrey Blanc-Lapierre; Valérie Seegers; Michèle Boisdron-Celle; Frédéric Bigot; Marianne Bourdon; Hakim Mahammedi; Aurélien Lambert; Mario Campone; Thierry Conroy et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Transient Vision Loss – A Rare Oxaliplatin-Induced Ophthalmologic Side Effect: A Report of Two Cases

Case Reports in Oncology
2021-03-18 | Journal article
DOI: 10.1159/000514656
Contributors: Loic Ah-Thiane; Jean-Luc Raoul; Sandrine Hiret; Hélène Senellart; Frédéric Dumont; Judith Raimbourg
Source: check_circle
Crossref

Retrorectal Mucinous Adenocarcinoma Arising from a Tailgut Cyst: A Case Report

Case Reports in Oncology
2021-03-01 | Journal article
DOI: 10.1159/000513028
Contributors: Manon Baverez; Emilie Thibaudeau; Vincent Libois; Olivier Kerdraon; Hélène Senellart; Jean-Luc Raoul
Source: check_circle
Crossref

Radiosensitizing Chemotherapy (Irinotecan) with Stereotactic Body Radiation Therapy for the Treatment of Inoperable Liver and/or Lung Metastases of Colorectal Cancer

Cancers
2021-01 | Journal article | Author
DOI: 10.3390/cancers13020248
Contributors: Loig Vaugier; Xavier Mirabel; Isabelle Martel-Lafay; Séverine Racadot; Christian Carrie; Véronique Vendrely; Marc-André Mahé; Hélène Senellart; Jean-Luc Raoul; Loic Campion et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

[Proton pump inhibitors and cancers: A hazardous association?]

Bulletin du cancer
2020-02 | Journal article
DOI: 10.1016/j.bulcan.2019.12.009
PMID: 32057465
Contributors: Raoul JL; Edeline J; Gilabert M; Senellart H; Frenel JS
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Systemic treatment of hepatocellular carcinoma: standard of care in China and elsewhere.

The Lancet. Oncology
2020-02 | Journal article
DOI: 10.1016/s1470-2045(20)30082-6
PMID: 32112736
Contributors: Raoul JL; Edeline J
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Hepatocellular carcinoma macroscopic gross appearance on imaging: predictor of outcome after transarterial chemoembolization in a real-life multicenter French cohort.

European journal of gastroenterology & hepatology
2019-11 | Journal article
DOI: 10.1097/meg.0000000000001420
PMID: 31045613
Contributors: Adhoute X; Pénaranda G; Raoul JL; Pietri O; Bronowicki JP; Castellani P; Perrier H; Monnet O; Bayle O; Oules V et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence.

Surgical oncology
2019-11 | Journal article
DOI: 10.1016/j.suronc.2019.10.018
PMID: 31707314
Contributors: Dumont F; Joseph S; Lorimier G; De Franco V; Wernert R; Verriele V; Kerdraon O; Campion L; Capitain O; Guerin-Meyer V et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Prognostication of HCC under sorafenib: Is it always possible?

Liver international : official journal of the International Association for the Study of the Liver
2019-11 | Journal article
DOI: 10.1111/liv.14294
PMID: 31705837
Contributors: Adhoute X; Pénaranda G; Raoul JL; Bourlière M
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Significance of lymph node involvement in local recurrence of colorectal cancer.

Journal of surgical oncology
2019-07 | Journal article
DOI: 10.1002/jso.25631
PMID: 31332806
Contributors: Dumont F; Muñoz MA; De Franco V; Wernert R; Verriele V; Heyman MF; Kerdraon O; Capitain O; Guerin-Meyer V; Raimbourg J et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Current options and future possibilities for the systemic treatment of hepatocellular carcinoma.

Hepatic oncology
2019-06 | Journal article
DOI: 10.2217/hep-2019-0001
PMID: 31244990
PMC: PMC6571544
Contributors: Raoul JL; Frenel JS; Raimbourg J; Gilabert M
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Sensitive and easy screening for circulating tumor cells by flow cytometry.

JCI insight
2019-06 | Journal article
DOI: 10.1172/jci.insight.128180
PMID: 31194699
PMC: PMC6675556
Contributors: Lopresti A; Malergue F; Bertucci F; Liberatoscioli ML; Garnier S; DaCosta Q; Finetti P; Gilabert M; Raoul JL; Birnbaum D et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report.

Case reports in oncology
2019-05 | Journal article
DOI: 10.1159/000500857
PMID: 31244646
PMC: PMC6587192
Contributors: Moisset L; Raimbourg J; Hiret S; Dauve J; Boisdron-Celle M; Senellart H; Raoul JL
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central
grade
Preferred source (of 2)‎

FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial.

European Journal of Cancer
2019-05 | Journal article
DOI: 10.1016/j.ejca.2019.04.020
PMID: 31129386
Contributors: Malka D; François E; Penault-Llorca F; Castan F; Bouché O; Bennouna J; Ghiringhelli F; de la Fouchardière C; Borg C; Samalin E et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Sorafenib: Experience and Better Manage-ment of Side Effects Improve Overall Survival in Hepatocellular Carcinoma Patients: A Real-Life Retrospective Analysis.

Liver cancer
2019-03 | Journal article
DOI: 10.1159/000497161
PMID: 31799203
Contributors: Raoul JL; Adhoute X; Penaranda G; Perrier H; Castellani P; Oules V; Bourlière M
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central
grade
Preferred source (of 2)‎

Characterization of subepithelial lesions of the stomach and esophagus by contrast-enhanced EUS: A retrospective study.

Endoscopic ultrasound
2019-01 | Journal article
DOI: 10.4103/eus.eus_89_17
PMID: 30264741
PMC: PMC6400084
Contributors: Pesenti C; Bories E; Caillol F; Ratone JP; Godat S; Monges G; Poizat F; Raoul JL; Ries P; Giovannini M
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Medical oncologists must get more involved in systemic treatment of hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology
2019-01 | Journal article
DOI: 10.1093/annonc/mdy471
PMID: 32081277
Contributors: Raoul JL; Faivre S; Frenel JS; Rimassa L
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

The New England journal of medicine
2018-12 | Journal article
DOI: 10.1056/nejmoa1809775
PMID: 30575490
Contributors: Conroy T; Hammel P; Hebbar M; Ben Abdelghani M; Wei AC; Raoul JL; Choné L; Francois E; Artru P; Biagi JJ et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein.

Journal of hepatocellular carcinoma
2018-11 | Journal article
DOI: 10.2147/JHC.S157413
PMID: 30464931
PMC: PMC6219272
Contributors: Gilabert M; Raoul JL
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence.

Cancer treatment reviews
2018-11 | Journal article
DOI: 10.1016/j.ctrv.2018.11.002
PMID: 30447470
Contributors: Raoul JL; Forner A; Bolondi L; Cheung TT; Kloeckner R; de Baere T
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial.

European Journal of Cancer
2018-10 | Journal article
DOI: 10.1016/j.ejca.2018.09.006
PMID: 30343254
Contributors: Bachet JB; Lucidarme O; Levache CB; Barbier E; Raoul JL; Lecomte T; Desauw C; Brocard F; Pernot S; Breysacher G et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Patients with resectable pancreatic adenocarcinoma: A 15-years single tertiary cancer center study of laparotomy findings, treatments and outcomes.

Surgical oncology
2018-08 | Journal article
DOI: 10.1016/j.suronc.2018.07.014
PMID: 30449481
Contributors: Gilabert M; Turrini O; Ewald J; Moureau-Zabotto L; Poizat F; Raoul JL; Delpero JR
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

European Journal of Cancer
2018-05 | Journal article
DOI: 10.1016/j.ejca.2018.03.031
PMID: 29807237
Contributors: Aparicio T; Ducreux M; Faroux R; Barbier E; Manfredi S; Lecomte T; Etienne PL; Bedenne L; Bennouna J; Phelip JM et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond.

Cancer treatment reviews
2018-05 | Journal article
DOI: 10.1016/j.ctrv.2018.05.006
PMID: 29783126
Contributors: Raoul JL; Kudo M; Finn RS; Edeline J; Reig M; Galle PR
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Journal of hepatology
2018-04 | Journal article
DOI: 10.1016/j.jhep.2018.03.019
PMID: 29628281
Contributors: European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals: a case-control study.

European journal of gastroenterology & hepatology
2018-04 | Journal article
DOI: 10.1097/meg.0000000000001082
PMID: 29384796
Contributors: Adhoute X; Penaranda G; Raoul JL; Sellier F; Castellani P; Oules V; Perrier H; Lefolgoc G; Pol B; Campanile M et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

[Hepatocellular carcinoma: Increase in incidence or future plague?]

Bulletin du cancer
2018-03 | Journal article
DOI: 10.1016/j.bulcan.2018.02.003
PMID: 29567280
Contributors: Raoul JL; Raimbourg J; Hiret S; Adhoute X; Senellart H
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response.

British journal of cancer
2017-11 | Journal article
DOI: 10.1038/bjc.2017.402
PMID: 29161241
PMC: PMC5785750
Contributors: Lamarca A; Barriuso J; Kulke M; Borbath I; Lenz HJ; Raoul JL; Meropol NJ; Lombard-Bohas C; Posey J; Faivre S et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.

Cell reports
2017-11 | Journal article
DOI: 10.1016/j.celrep.2017.11.003
PMID: 29186684
PMC: PMC6082139
Contributors: Nicolle R; Blum Y; Marisa L; Loncle C; Gayet O; Moutardier V; Turrini O; Giovannini M; Bian B; Bigonnet M et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

The Lancet. Oncology
2017-10 | Journal article
DOI: 10.1016/s1470-2045(17)30683-6
PMID: 29107679
Contributors: Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Intermediate stage treatment: Is TACE enough?

Liver international : official journal of the International Association for the Study of the Liver
2017-10 | Journal article
DOI: 10.1111/liv.13598
PMID: 28952186
Contributors: Adhoute X; Penaranda G; Raoul JL; Bourlière M
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Using a very low-density SNP panel for genomic selection in a breeding program for sheep.

Genetics, selection, evolution : GSE
2017-10 | Journal article
DOI: 10.1186/s12711-017-0351-0
PMID: 29065868
PMC: PMC5655911
Contributors: Raoul J; Swan AA; Elsen JM
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

A 25-gene classifier predicts overall survival in resectable pancreatic cancer.

BMC medicine
2017-09 | Journal article
DOI: 10.1186/s12916-017-0936-z
PMID: 28927421
PMC: PMC5606023
Contributors: Birnbaum DJ; Finetti P; Lopresti A; Gilabert M; Poizat F; Raoul JL; Delpero JR; Moutardier V; Birnbaum D; Mamessier E et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

An in-depth review of chemical angiogenesis inhibitors for treating hepatocellular carcinoma.

Expert opinion on pharmacotherapy
2017-09 | Journal article
DOI: 10.1080/14656566.2017.1378346
PMID: 28893090
Contributors: Raoul JL; Gilabert M; Adhoute X; Edeline J
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.

Annals of oncology : official journal of the European Society for Medical Oncology
2017-09 | Journal article
DOI: 10.1093/annonc/mdx330
PMID: 28911069
Contributors: Thierry AR; El Messaoudi S; Mollevi C; Raoul JL; Guimbaud R; Pezet D; Artru P; Assenat E; Borg C; Mathonnet M et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

How to treat pancreatic adenocarcinoma in elderly: How far can we go in 2017?

Journal of geriatric oncology
2017-09 | Journal article
DOI: 10.1016/j.jgo.2017.08.007
PMID: 28888554
Contributors: Gilabert M; Raoul JL; Rousseau F
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Response to 'the flexible therapeutic approach to the BCLC B stage': Time for scoring systems?

Journal of hepatology
2017-09 | Journal article
DOI: 10.1016/j.jhep.2017.07.038
PMID: 28919471
Contributors: Adhoute X; Pénaranda G; Sellier F; Raoul JL
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.

European Journal of Cancer
2017-08 | Journal article
DOI: 10.1016/j.ejca.2017.07.038
PMID: 28829992
Contributors: Bascoul-Mollevi C; Gourgou S; Galais MP; Raoul JL; Bouché O; Douillard JY; Adenis A; Etienne PL; Juzyna B; Bedenne L et al.
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

Optimal mating strategies to manage a heterozygous advantage major gene in sheep.

Animal : an international journal of animal bioscience
2017-08 | Journal article
DOI: 10.1017/s1751731117001835
PMID: 28770690
Contributors: Raoul J; Palhière I; Astruc JM; Swan A; Elsen JM
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central

[Patient participation in medical decision-making: From concept to reality in oncology].

Bulletin du cancer
2017-07 | Journal article
DOI: 10.1016/j.bulcan.2017.06.002
PMID: 28688746
Contributors: Raoul JL; Maraninchi D
Source: Self-asserted source
Jean-Luc Raoul via Europe PubMed Central
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 7

Peer review (1 review for 1 publication/grant)

Review activity for Cancers. (1)
How many people are using ORCID?